FactSet (FDS)
NYSEFinancialsFinancial Data & Stock ExchangesSnapshot 2026-07-07
$258.34+2.43%
Close 2026-07-07 · 1-day change
Reading FDS? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track FDS free→NYSEFinancialsFinancial Data & Stock ExchangesSnapshot 2026-07-07
Reading FDS? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track FDS free→QuarterlyIQ Insights · FDS
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 14 valuation methods, at three horizons. Current price $258.34. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $258 FDS trades at 15× p/e, below its 17× p/e peer median. Our $276 fair value sits above the price. We hold it with medium confidence: quality doesn't explain valuation multiples in this sub-industry, so the peer comparison is a weak guide. Analysts target $210–$340. Not investment advice.
$210.00 – $340.00 (median $246.50) · 12 analysts · as of 2026-07-06
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Cheaper than its own typical valuation.
Trailing four: 2025-Q3, 2026-Q1, 2026-Q2, 2026-Q3
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $246.50 | — | — | Analyst | high |
| dcf fcfe | 12M | $436.14 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $444.26 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $78.95 | — | — | TTM | high |
| graham number | 12M | $148.91 | — | — | TTM | high |
| Mgmt guidance | 12M | $289.60 | 16.5 | 17.50 | Mgmt | high |
| Peer P/B | 12M | $117.82 | 2.1 | 56.15 | TTM | high |
| Peer P/FCF | 12M | $266.26 | 13.6 | 19.57 | TTM | high |
| Peer P/E | 12M | $290.42 | 16.5 | 17.55 | TTM | high |
| Peer P/S | 12M | $227.36 | 3.4 | 67.38 | TTM | high |
| PEG | 12M | $348.59 | 19.9 | 17.55 | TTM | high |
| residual income | 12M | $106.60 | — | — | TTM | high |
| Own P/E history | 12M | $404.55 | 23.1 | 17.55 | TTM | high |
| triangulated | 12M | $298.32 | 16.5 | 18.03 | Triangulated | high |
| Mgmt guidance | 3Y | $389.14 | 16.5 | 23.52 | Mgmt(prov.) | medium |
| Peer P/B | 3Y | $143.48 | 2.1 | 68.38 | Hist. CAGR(prov.) | medium |
| Peer P/FCF | 3Y | $334.01 | 13.6 | 24.55 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $329.43 | 16.5 | 19.91 | Analyst | medium |
| Peer P/S | 3Y | $246.77 | 3.4 | 73.13 | guidance | medium |
| PEG | 3Y | $395.40 | 19.9 | 19.91 | Analyst | medium |
| Own P/E history | 3Y | $458.88 | 23.1 | 19.91 | Analyst | medium |
| Mgmt guidance | 5Y | $473.86 | 16.5 | 28.63 | Mgmt(prov.) | high |
| Peer P/B | 5Y | $163.62 | 2.1 | 77.98 | Hist. CAGR(prov.) | high |
| Peer P/FCF | 5Y | $388.51 | 13.6 | 28.56 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $333.91 | 16.5 | 20.18 | Analyst | high |
| Peer P/S | 5Y | $250.13 | 3.4 | 74.13 | guidance | high |
| PEG | 5Y | $400.78 | 19.9 | 20.18 | Analyst | high |
| Own P/E history | 5Y | $465.13 | 23.1 | 20.18 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.